aprevo® anterior and lateral lumbar interbody system +3 more— 510(k) K260385

Name: FDA 510(k) clearance K260385
Creator: U.S. Food and Drug Administration
Published: 2026-05-09

Substantially Equivalent

Carlsmed, Inc.

FDA 510(k) clearance K260385 for aprevo® anterior and lateral lumbar interbody system +3 more, Substantially Equivalent on 2026-05-09. Applicant: Carlsmed, Inc.. Device class: 2.

Clearance details

Device name as filed: aprevo® anterior and lateral lumbar interbody system; aprevo® posterior and transforaminal lumbar interbody system; aprevo® cervical interbody system; corra cervical plating system
Applicant: Carlsmed, Inc.
Product code: Code MAX
Device class: Class 2
Regulation: 21 CFR 888.3080
Advisory panel: Orthopedic
Date received: 2026-02-06
Decision date: 2026-05-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Carlsbad, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MAX

view all

K261049 — SCALA® TL2026-08-20
K261430 — TruLift Expandable System2026-07-28
K253011 — Catalyft PL Expandable Interbody System2026-07-17
K261020 — Symmetrix L Spinal System2026-07-14
K253420 — Admiral ACP System +18 more2026-07-01

More clearances from Carlsmed, Inc.

view all

K260570 — corra cervical plating system2026-04-22
K252894 — aprevo® cervical interbody system2026-01-06
K252611 — aprevo® cervical plating system2025-12-22
K250827 — aprevo® anterior lumbar interbody fusion device +7 more2025-07-07
K250987 — aprevo® posterior/transforaminal lumbar interbody fusion device2025-06-30

Adverse events under product code MAX

product code MAX

Death: 13
Injury: 1,305
Malfunction: 2,885
Total: 4,203

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.